Pembrolizumab for Early Triple-Negative Breast Cancer
Among patients with early triple-negative breast cancer, the percentage with a pathological complete response was significantly higher among those who received pembrolizumab plu...
Publications
1 shownFrequent Co-Authors
Researcher Info
- h-index
- 1
- Publications
- 1
- Citations
- 2,718
- Institution
- Baylor University Medical Center
External Links
Identifiers
- ORCID
- 0000-0002-2955-5523
Impact Metrics
h-index
1
h-index: Number of publications with at least h citations each.